Please select the option that best describes you:

What guides your choice between prophylactic, intermediate, and full therapeutic dosing of enoxaparin in a woman with APLS and prior fetal loss with no hx of thromboembolic disease?  



Answer from: at Academic Institution
Comments
at The Mass General Porphyria Center
Thanks for this answer! I personally do not contin...
Sign In or Register to read more

Answer from: at Academic Institution
Sign In or Register to read more